Dr. Kandarpa Discusses Favorable Phase III Trial Results for Delcath’s Percutaneous Hepatic Perfusion (PHP) System
NEW YORK--(BUSINESS WIRE)-- Wall Street Media presents exclusive video of Dr. Krishna Kandarpa, MD, Ph.D, the internationally renowned Cardiovascular & Interventional Radiologist and Delcath Systems’ (Nasdaq:DCTH) Chief Medical Officer, on PHP’s positive trial results and platform technology.
Dr. Kandarpa completed his residency in Radiology at Brigham and Women’s Hospital and Harvard Medical School, where he also completed his fellowship in cardiovascular & interventional radiology. He was Chair of the Department of Radiology at the University Of Massachusetts Medical School. He is listed among Best Doctors in America and America’s Top Doctors.
Please visit the following link to view the video:
http://wsmco.com/show.aspx?1663_Facts_on_DCTH's_PHP_System
Follow and learn from Wall Street Media on StockTwits:
Wall Street Media presents exclusive insights from the leading transparent investors on the planet:
CONTACT:
Wall Street Media
Claire McCurry, 212-354-1102
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Health Cardiology Clinical Trials Hospitals Radiology Professional Services Finance
MEDIA: